Showing 9,601 - 9,620 results of 34,719 for search '(( 50 ((we decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( e non decrease ))', query time: 1.11s Refine Results
  1. 9601

    Image_3_Microarray Analysis of lncRNA and mRNA Reveals Enhanced Lipolysis Along With Metabolic Remodeling in Mice Infected With Larval Echinococcus granulosus.TIF by Yang Lu (59885)

    Published 2020
    “…Overall, the present study suggested that E. granulosus infection could enhance lipolysis. …”
  2. 9602

    Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

    Published 2025
    “…<p>The control non-diabetic group was administered with the vehicle used for dissolving the STZ, i.e., 100mM sodium citrate buffer, pH 4.5. …”
  3. 9603

    DataSheet1_The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.docx by Nanyong Gao (12220706)

    Published 2022
    “…In an in vivo study, Sprague–Dawley (SD) rats were randomly divided into groups, with six animals per group, receiving osimertinib with or without rabeprazole, omeprazole, and lansoprazole. We found that the AUC<sub>(0–t)</sub>, AUC<sub>(0–∞)</sub>, and C<sub>max</sub> of osimertinib decreased significantly after co-administration with rabeprazole orally, but they increased remarkably when osimertinib was administered through intraperitoneal injection. …”
  4. 9604
  5. 9605

    Table1_Exploration on the effect of anserine on the alleviation of DVT and its molecular mechanism.docx by Yan Li (23143)

    Published 2024
    “…</p>Results<p>Anserine alleviated HUVECs injury, reduced adhesion molecule expression, and inflammation. It decreased P-selectin, E-selectin, vWF, THBD, TFPI levels, and apoptosis while promoting NOS3, ET-1, and NO release in HUVECs. …”
  6. 9606
  7. 9607
  8. 9608
  9. 9609
  10. 9610
  11. 9611

    Mitochondrial respiration presented as oxygen flux (O<sub>2</sub> flux, pmol<sup>.</sup>s<sup>-1.</sup>mg<sup>-1</sup>) in skeletal muscle in Non-raced and Raced Alaskan Huskies. by Benjamin Miller (3954770)

    Published 2017
    “…However, when only NADH-linked substrates were provided (B), Complex (C) I phosphorylation (CI<sub>P</sub>), uncoupled CI and CII ((CI&CII)<sub>E</sub>), and CII only (CII<sub>E</sub>) respiration are significantly greater in the Raced compared to Non-raced dogs. …”
  12. 9612

    PRISMA flow chart of the screening process. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  13. 9613

    Forest plot of liver function tests. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  14. 9614

    Subgroup analysis of BUN based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  15. 9615

    Subgroup analysis of ICU Stay based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  16. 9616

    GRADE evidence profile. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  17. 9617

    Characteristics of included studies. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  18. 9618

    Sensitivity analysis for BUN. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  19. 9619

    Subgroup analysis of BUN based on surgery type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  20. 9620

    Baseline Characteristics of Included Patients. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”